Corin’s OPSInsight Gains FDA Clearance for Total Hip Replacement

By Julie A. Vetalice

Corin’s OPSInsight Gains FDA Clearance for Total Hip Replacement

Corin received FDA 510(k) clearance for OPSInsight™, cloud-based software that allows surgeons to access and adjust customized pre-operative plans for total hip arthroplasty. This is the latest evolution of the company's Optimized Positioning System (OPS™), which uses pre-operative functional imaging to plan optimal implant alignment while considering individual patient anatomy, spinopelvic mobility and functional biomechanics.

OPSInsight, part of the CorinConnect™ ecosystem, supports access to additional information like advanced spinopelvic assessment, impingement analysis and radiodensity mapping.

Personalized technologies deployed within CorinConnect generate actionable insights on a customizable dashboard before, during and after the procedure.

Corin’s Chief Innovation Officer, Jim Pierrepont, Ph.D., said, “Our belief is that OPSInsight is the new gold standard in THA planning. The possible depth of analysis is unparalleled, and key insights are presented in an intuitive and user-friendly interface to our surgeons. We believe this level of planning is a necessity to improve outcomes in THA.”

Product Labels: Hip Replacement

Tags: 510(k) Clearance, Regulatory